Get your Health question answered in 3 easy steps
A Doctor will be with you shortly
Ask a Doctor Now
164 Doctors are Online

What should I do for mild case of ADD at the age of 22 years ?

a family friend thinks i have a case or mild case of ADD I am 22 years old and i have a family friend who has a son with ADHD and she thinks i might have a case or mild case of ADD what should i do ?
Asked On : Wed, 16 Mar 2011
Answers:  2 Views:  148
Report Abuse
Share on Facebook
Share on Twitter
Share on Google+
Question is related to
Diseases and Conditions
Psychiatrist, Child 's  Response
Why your family friend feels that you have mild ADD?
If you do not get any disturbances secondarily the symptoms mentioned by your friend that are suggestive of ADD, nothing to worrry.
If you have disturbaces with that do meditation, relaxation, see for changes.
If not getting benefit consult psychiatrist at your place.
Answered: Thu, 28 Apr 2011
I find this answer helpful

1 Doctor agrees with this answer

  User's Response
Zaar Memory Sure is the only clinically proven, well researched cognitive enhancer authorized by India’s premier research institute, CDRI/CSIR. It overall enhances mental retention capacity and is safe and non-toxic. It not only facilitates learning, improves consolidation of learned behavior but also reduces anxiety in adults and children that enhances focus and concentration in logical memory, digit forward and paired associated learning. It improves mental alertness and sharpens short-term and long-term memory.

Who can benefit from BESEB?

The results of the above clinical trials conducted by CDRI/CSIR in India and also in Australia prove that it is good for the prevention & early treatment of dementia.
• For Attention Deficit Hyperactivity Disorder (ADHD) in Children
• For Age Associated Memory Impairment (AAMI) in elderly persons
• For those with stress, tension, anxiety and want to improve their memory

What are the benefits of BESEB?

• Enhances Memory
• Improves Learning
• Helps in Concentration
• Reduces anxiety and Stress
• Assists cerebral blood circulation flow
• Acts as an antioxidant
• Neuroprotection

What is the safety profile of BESEB?

BESEB is found to be safe under various studies conducted by CDRI (CSIR) in laboratory animals and double blind cross over clinical trial studies in children and elderly subjects

How and why does the CDRI Brahmi extract BESEB differ from other Brahmi extracts?

Each capsule of BESEB contains a standardized and an optimum quantity of the enriched Bacosides A and B extracted from the plant Bacopa monniera as per CDRI(CSIR) quality control parameters. These bacosides are extracted based on a unique process know-how, developed and patented by the CDRI(CSIR).

Central Drug Research Institute (CDRI), Lucknow, a constituent laboratory of Council of Scientific & Industrial Research (CSIR), New Delhi, India has developed a unique single plant based natural memory enhancer formulation – BESEB (“Bacosides Enriched Standardized Extract of Bacopa”) from the herb Bacopa monniera. The plant is commonly known as Brahmi which has been used in the Indian System of Ayurvedic Medicine as a traditional herb for over 3000 years to enhance memory and learning.

BESEB is successfully commercialized and its efficacy has been established by CDRI (CSIR), Lucknow. It has been licensed to M/s Lumen Marketing Co., Chennai for manufacturing and marketing. Lumen is selling the product under different brand names with its business associates mainly as
• Memo Plus Gold in Malaysia, Philippines & Singapore,
• Keenmind & Membac in Australia & New Zealand and
• Memory Perfect in France & Germany.
• Lumen and Zaar Distributors Pvt. Ltd., New Delhi joined hands for extensive marketing of the product in India as Memory Sure.
• It will soon to be available in Thailand, Indonesia, SAARC countries, the UAE and CIS (former Soviet states).

Clinical trials in India & Australia using CDRI (CSIR) – BESEB:
• CDRI clinical trials on Attention Deficit Hyperactivity Disorder (ADHD) in children.
• CDRI clinical trials on Age Associated Memory Impairment (AAMI) in old age subjects.
• Swinburne University of Technology’s Brain Sciences Institute (BSI), Australia through the National Institute of Complementary Medicine (NICM): Clinical trials on Healthy human volunteers published in international journal Psychopharmacology-2001.
• University of Wollongong, Australia: Clinical trials on Healthy human volunteers published in international forum Neuropsychopharmacology-2002.
• Australian Government funded initiative was established in 2007 to seek out scientifically valid evidence for alternative therapies, allowing them to become part of mainstream treatment, particularly for priority health issues such as the prevention and early treatment of Dementia.
Answered: Wed, 11 May 2011
Disclaimer: These answers are for your information only and not intended to replace your relationship with your treating physician.
This is a short, free answer. For a more detailed, immediate answer, try our premium service [Sample answer]


Loading Online Doctors....
© Ebix, Inc. All Rights Reserved.
All the information, content and live chat provided on the site is intended to be for informational purposes only, and not a substitute for professional or medical advice. You should always speak with your doctor before you follow anything that you read on this website. Any health question asked on this site will be visible to the people who browse this site. Hence, the user assumes the responsibility not to divulge any personally identifiable information in the question. Use of this site is subject to our Terms & Conditions
Already Rated.
Your rating:

Ask a Doctor